Yingjun Jiang Selected Research

2'- cyano- 2'- deoxyarabinofuranosylcytosine

12/2019	CNDAC-Induced DNA Double-Strand Breaks Cause Aberrant Mitosis Prior to Cell Death.
1/2018	Targeting BRCA1/2 deficient ovarian cancer with CNDAC-based drug combinations.
10/2016	Mechanism-Based Drug Combinations with the DNA Strand-Breaking Nucleoside Analog CNDAC.
8/2005	Molecular basis for G2 arrest induced by 2'-C-cyano-2'-deoxy-1-beta-D-arabino-pentofuranosylcytosine and consequences of checkpoint abrogation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yingjun Jiang Research Topics

Disease

5	Neoplasms (Cancer) 01/2021 - 10/2016
3	Chromosome Aberrations (Chromosome Abnormalities) 12/2019 - 08/2005
3	Hematologic Neoplasms (Hematological Malignancy) 01/2018 - 08/2005
1	Insulin Resistance 01/2022
1	Body Weight (Weight, Body) 01/2022
1	Urticaria (Hives) 01/2021
1	Urologic Neoplasms (Urological Cancer) 01/2021
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Kidney Neoplasms (Kidney Cancer) 01/2021
1	Prostatic Neoplasms (Prostate Cancer) 12/2020
1	Stomach Neoplasms (Stomach Cancer) 12/2019
1	Ovarian Neoplasms (Ovarian Cancer) 01/2018
1	Fanconi Anemia (Fanconi's Anemia) 03/2013
1	Ataxia Telangiectasia (Louis Bar Syndrome) 08/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2011

Drug/Important Bio-Agent (IBA)

4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 08/2011
4	2'- cyano- 2'- deoxyarabinofuranosylcytosineIBA 12/2019 - 08/2005
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 01/2011
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2021
2	ProdrugsIBA 01/2018 - 10/2016
2	sapacitabineIBA 01/2018 - 10/2016
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2022
1	AntioxidantsIBA 01/2022
1	Insulin (Novolin)FDA Link 01/2022
1	C-PeptideIBA 01/2022
1	Peptides (Polypeptides)IBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	caffeic acid phenethyl esterIBA 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Propolis (Bee Bread)IBA 01/2021
1	Biological ProductsIBA 12/2020
1	Pharmaceutical PreparationsIBA 12/2019
1	Small Interfering RNA (siRNA)IBA 12/2019
1	Platinum Compounds (Compounds, Platinum)IBA 01/2018
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2018
1	Taxoids (Taxanes)IBA 01/2018
1	NucleosidesIBA 01/2018
1	Drug CombinationsIBA 01/2018
1	EnzymesIBA 03/2013
1	NK314IBA 08/2011
1	DNA-Activated Protein KinaseIBA 08/2011
1	HomoharringtonineIBA 01/2011
1	7-hydroxystaurosporine (UCN 01)IBA 08/2005

Therapy/Procedure

2	Therapeutics 01/2018 - 08/2005